RaySearch Laboratories builds advanced software for cancer radiation therapy, led by the RayStation treatment-planning system used in clinics worldwide. Its tools support planning across photons, electrons, protons and heavier ions, with strengths in adaptive therapy and multi-criteria optimization that help centers get more from complex treatment machines. Hospitals and cancer centers adopt RaySearch systems as a clinical IT layer for planning and oncology workflow, not as hardware vendors.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 331.7 | — | 56.8 | — |
| Q2 2025 | 304.9 | — | 30.8 | — |
| Q3 2025 | 332.3 | — | 71.6 | — |
| Q4 2025 | 375.4 | — | 68.6 | — |
| Q1 2026 | 290.3 | -12.5% | 53.2 | -6.3% |
All markets — KeepWinning global stock screener
Other companies on Stockholm: Salix Group AB (publ) (SALIX), Karnell Group AB (publ) (KARNEL B), NOTE AB (publ) (NOTE), Nyab AB (publ) (NYAB), Ependion AB (EPEN), Morrow Bank AB (MORROW)